CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: March 15, 2010
Result type: Reports
Project Number: SR0199-000
Product Line: Reimbursement Review

Generic Name: Calcitriol

Brand Name: Silkis

Manufacturer: Galderma Canada Inc.

Therapeutic Area: Psoriasis, mild to moderate plaque

Indications: Psoriasis, mild to moderate plaque

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 22, 2010

Recommendation Type: Do not list